Nuclide Therapeutics
Nuclide Therapeutics is developing next-generation targeted radiopharmaceutical therapies for treatment-resistant cancer.
Nuclide Therapeutics is a tech company based in London, United Kingdom, started in 2024. Nuclide Therapeutics is developing next-generation targeted radiopharmaceutical therapies for treatment-resistant cancer.
- Website
- nuclidetx.com
- City
- London
- Country
- United Kingdom
- Founded
- 2024
- AI-native
- No
- Registered
- Company 15734758
More Health & bio in London
Basecamp ResearchLab
Biological data and models from global biodiversity.
Francis Crick InstituteLab
Biomedical discovery institute in central London.
Isomorphic LabsLabMafia
AI-first drug design spun out of DeepMind.
Latent LabsLabMafia
Generative models for protein design.
Ochre Bio
RNA medicines for liver diseases
Digistain
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
Claim this profile
Free and instant: prove you run nuclidetx.com and edit the profile yourself.
- Your logo, office address and founder photos
- The ✓ Verified mark next to Nuclide Therapeutics across the site
- Open roles listed on the Hiring board
- A followed link back to your website
A rank card with Nuclide Therapeutics's standing on Labspie, or a simple badge. Both link to this profile and update themselves.
